Wednesday, May 22, 2024

Don't Miss

Clinical Trials

Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024

Establishment Labs Holdings Inc., a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, noted the...

Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary Endpoints

Caliway Biopharmaceuticals announced the topline results of the CBL-0201EFP Phase 2 study, which met all the primary and secondary efficacy endpoints in the ITT...

EVENTS

Funding

Stay Connected

16,985FansLike
2,458FollowersFollow
61,453SubscribersSubscribe
- Advertisement -

Featured

Latest Reviews

Mergers & Acquisitions

Johnson & Johnson to Acquire Proteologix

Johnson & Johnson entered into a definitive agreement to acquire Proteologix, Inc., a Redwood City, California-based biotechnology company focused on bispecific antibodies for immune-mediated...

Alpha Aesthetics Partners Announces partnership with RN Esthetics, led by Michelle Doran

Alpha Aesthetics Partners, a Thurston Group portfolio company, proudly announces its partnership with RN Esthetics, an award-winning medical aesthetic practice with three state-of-the-art locations...

BENEV Partners with RepeatMD to Elevate Patient Experience in Medical Aesthetics

BENEV, a leading FDA-registered manufacturer renowned for its innovative products in the health and beauty market, is pleased to announce a strategic partnership with...

BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology

BioRestorative Therapies, Inc., a clinical stage company focused on stem cell-based therapies, today announced that it has entered into a five-year exclusive supply agreement...

Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments

ELEVAI LABS, inc. announced that it has entered into an exclusive licensing agreement with MOA Life Plus Co., Ltd., (“MOA”) a South Korean corporation,...
- Advertisement -
Advertismentspot_imgspot_img
Advertismentspot_imgspot_img